首页> 外文期刊>Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA >Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99m sestamibi and I-123 for localization of rapid washout parathyroid adenomas
【24h】

Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99m sestamibi and I-123 for localization of rapid washout parathyroid adenomas

机译:TC99M Sestamibi和I-123对双放射性药物孵化的甲状旁腺功能亢进类型及效用的比较,对快艇甲状旁腺腺瘤定位

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The SummaryTc99m-sestamibi dual-time imaging is a standard tool for localization of adenomas/hyperplasia in hyperparathyroidism. We investigated the degree and causes of localization failure among different types of hyperparathyroidism. Pre-operative parathyroid hormone levels and size of the gland were major determinants of Tc99m-sestamibi positivity; I-123 scan may be helpful in localization failures.IntroductionTc99m-sestamibi dual-time imaging is a standard tool for localization of adenomas/hyperplasia in hyperparathyroidism. However, parathyroid adenomas/hyperplasia has been reported to washout as fast as normal thyroid tissue (rapid washout) which may lead to diagnostic failure. We aimed to evaluate the determinants of rapid washout and to determine the role of subtraction imaging for detection of parathyroid adenomas/hyperplasia with rapid washout.MethodsRetrospective analysis of patients with hyperparathyroidism who have undergone Tc99m-sestamibi dual-time imaging and parathyroid surgery. Rapid washout was correlated to the type of hyperparathyroidism in surgically confirmed cases. Biochemical and pathological data were reviewed.ResultsA total of 135 hyperparathyroidism patients met the inclusion criteria. Ninety-six (72%), 29 (21%), and 10 (7%) had primary, secondary, and tertiary hyperparathyroidisms, respectively. Rapid washout was identified in 28/87 glands (32%), 14/53 glands (26%), and 1/16 glands (6%) with primary, secondary, and tertiary hyperparathyroidisms, respectively. Glands that were positive on late-phase Tc99m-sestamibi scans were significantly large being 1.7 (IQR 1.4-2.3) vs. 1.45 (IQR 1-2)cm (p=0.003). High parathyroid hormone levels (PTH) were associated with early-phase Tc99m-sestamibi positivity in both primary (p=0.01) and secondary hyperparathyroidism (p=0.03) but not with last phase (p=0.11, p=0.37, respectively). Correlative imaging with subtraction scintigraphy was positive in 14/16 (87.5%) parathyroid adenomas.ConclusionPre-operative PTH levels and size of the gland were major determinants of Tc99m-sestamibi positivity on early-phase Tc99m-sestamibi scans, whereas size is an independent predictor of late-phase Tc99m-sestamibi positivity. Subtraction scintigraphy might be a useful tool in suspected cases of rapid washout adenomas/hyperplasia.
机译:SublutiontC99M-Sestamibi双时成像是甲状腺功能亢进症腺瘤/增生的定位标准工具。我们调查了不同类型的甲状旁腺功能亢进中定位失败的程度和原因。患有前甲状旁腺激素水平和腺体的大小是TC99M-Sestamibi积极性的主要决定因素; I-123扫描可能有助于本地化故障。introductiontc99m-sestamibi双时成像是甲状腺功能亢进症腺瘤/增生的定位标准工具。然而,据报道,甲状旁腺腺瘤/增生以迅速用作正常的甲状腺组织(快速冲洗),这可能导致诊断失败。我们的目标是评估快速冲洗的决定因素,并确定减去成像检测对甲状旁腺腺瘤/增生的作用,具有快速冲洗。患有TC99M-Sestamibi双时成像和甲状旁腺手术的甲状腺功能亢进患者的方法分析。快速冲洗与手术确诊病例中的甲状旁腺功能亢进的类型相关。审查了生物化学和病理数据。培养了135例甲状腺功能亢进患者的总和达到纳入标准。百分之九十六(72%),29(21%)和10(7%)分别具有初级,次要和三级甲状旁腺功能亢进。在28/87腺体(32%),14/53个腺体(26%)和1/16腺体(6%)中鉴定出快速冲洗,分别具有初级,次级和三级甲状旁腺功能亢进。在晚期TC99M-SESTAMIBI扫描上为阳性的腺体显着大为1.7(IQR 1.4-2.3)与1.45(IQR 1-2)CM(P = 0.003)。高甲状旁腺激素水平(PTH)与初级(P = 0.01)和继发性甲状旁腺功能亢进(P = 0.03)中的早期TC99M-Sestamibi阳性相关(P = 0.03),但不具有最后相(P = 0.11,P = 0.37)。与减法的相关成像在14/16(87.5%)甲状旁腺腺瘤中呈阳性阳性腺瘤.Conclusionpre-术治疗Pth水平和腺体的大小是TC99M-Sestamibi阳性的主要决定因素在早期TC99M-Sestamibi扫描,而大小是独立的晚期TC99M-Sestamibi积极性的预测因子。减法闪烁术可能是一种有用的涉嫌早熟腺瘤/增生病例的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号